IL10 and inflammatory bowel disease: Thus, even though Il10−/− mast cells produce elevated levels of inflammatory mediators when stimulated in vitro, the absence of mast cells does not affect the severity of IBD triggered by exposure of Il10−/− mice to the mucosal barrier-damaging NSAID piroxicam.